Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
Price Target
Average
839.23%
Revenue Forecast
Estimate
679.29%
EBIT
Estimate
56.19%
Net Income
Estimate
5.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Keros Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for KROS of $102 , with forecasts ranging from
a
low of
$96 to a high of $107 .
KROS Lowest Price Target
Wall Street Target
96 USD
783.98%
KROS Average Price Target
Wall Street Target
102 USD
839.23%
KROS Highest Price Target
Wall Street Target
107 USD
885.27%
REVENUE FORECAST
Revenue Forecast Chart KROS
EBIT FORECAST
EBIT Forecast Chart KROS
NET INCOME FORECAST
Net Income Chart KROS